Cleared Abbreviated

K183574 - SRX Handheld Doppler, DMX Handheld Doppler, Obstetric Probes, Vascular Probes (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K183574 · Huntleigh Healthcare , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
259d
Days
Class 2
Risk

K183574 is an FDA 510(k) clearance for the SRX Handheld Doppler, DMX Handheld Doppler, Obstetric Probes, Vascular Probes. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Huntleigh Healthcare , Ltd. (Cardiff, GB). The FDA issued a Cleared decision on September 6, 2019 after a review of 259 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Huntleigh Healthcare , Ltd. devices

Submission Details

510(k) Number K183574 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2018
Decision Date September 06, 2019
Days to Decision 259 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
134d slower than avg
Panel avg: 125d · This submission: 259d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 136
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K183574.
FloPatch FP120
K252810 · Flosonics Medical · Apr 2026
VascuChek Kit, VascuChek Transceiver, VascuChek Clinical Probe, VascuChek Speaker Dock (VC-KIT-02, VC-TRX-02, VC-CP-01, VC-SD-01)
K251904 · Remington Medical, Inc. · Nov 2025
FloPatch FP120
K251114 · Flosonics Medical · Jun 2025
Elfor-L
K243852 · Elfi-Tech , Ltd. · Apr 2025
VascuChek Kit, VascuChek Transceiver, VascuChek Clinical Probe, VascuChek Charger (VC-KIT-01, VC-TRX-01, VC-CP-01, VC-CH-01)
K241583 · Remington Medical, Inc. · Aug 2024
FloPatch FP120
K223843 · Flosonics Medical · May 2023